Estimating time to disease progression comparing transition models and survival methods – an analysis of multiple sclerosis data.

This article reports an analysis that aims to quantify the effect of fingolimod, an oral treatment for relapsing remitting multiple sclerosis (MS), on disability progression. The standard approach utilizes survival analysis methods, which may be problematic for MS studies that assess disability at only a few time points and include as a cardinal feature both […]

Read More
Learn More